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Human breast cancer (HBC) incidence varies worldwide (Parkin
et al, 1997). People moving from areas of lower to higher HBC
incidence show a gradually acquired increase in risk. For example,
the Japanese moving to the USA (Ziegler et al, 1993), Soviet Jews
to Israel (Iscovich and Howe, 1998) and south Asians to the UK
(Winter et al, 1999) all experience increased incidences of breast
cancer over a period of decades. Changes in the environment are
universally agreed to account for the increased risk for breast
cancer (Hunter et al, 1997). Genetic factors (inherited mutations in
BRCA1 and BRCA2) account for about 5% of HBC (Szabo and
King, 1997). Diets high in fat and xeno-oestrogens have been
proposed to increase HBC incidence, whereas phyto-oestrogens
may have a protective effect, although none of these hypotheses
have shown a correlation to the migration effect (Hunter et al,
1996, 1997; Holmes et al, 1999). Moreover, the circumpolar Inuit
have a low breast cancer incidence, half that in Canada (Miller and
Gaudette, 1996), but have a high saturated fat diet that is low in
phyto-oestrogens and is contaminated with high levels of xeno-
oestrogens (Ayotte et al, 1997). Some other, unrecognized,
environmental factors with oncogenic potential must explain the
geographic differences in HBC incidence.
Mouse mammary tumour virus (MMTV) is an oncogenic B-
type retrovirus that causes breast cancer in mice. MMTV env
gene-like sequences are found in 38–40% of HBC and are 95–98%
identical to MMTV over 660 bp of sequence, but not to other
known human endogenous retroviruses (Wang et al, 1995). These
authors have recently extended these findings by isolating 9.9 kb
fragments from two human breast carcinomas containing env, gag,
pol and LTR genes 94% homologous to MMTV, but only 90%
homologous to each other (Liu et al, 1999). The presence of
MMTV in HBC has been confirmed in two independent studies
(Imai, 1996; Lushnikova et al, 1998). Similarity of the complete
genomes among different MMTV strains in mice is also about
95% (Nishio et al, 1994), arguing that human MTVs are acquired
from mice. These DNA findings lend credence to earlier reports of
MMTV-like particles (Dmochowski et al, 1969) and antibody
responses to MMTV proteins (Day et al, 1981) in breast tumours.
Strong support for humans becoming infected with MMTV
comes from a study of laboratory personnel working with MMTV-
infected mice. They were found to develop a specific serologic
response to MMTV when compared to age- and gender-matched
controls, most strongly to gp55, a surface glycoprotein of MMTV
(Dion et al, 1986). This retrospective study was prompted by
reports of immune reactivity to MMTV in exposed laboratory
personnel (Holder et al, 1976; Wiseman et al, 1980; Lopez et al,
1981). Most notably was the case of a woman working with
MMTV-infected mice. Over a 28-month period she was seronega-
tive by enzyme-linked immunosorbent assay (ELISA) and indirect
immunofluorescence, but at the 32nd month she seroconverted.
Nine months later a small mass in her right breast was discovered,
diagnosed 3 months later as an infiltrating ductal carcinoma (Poon
et al, 1983). From these reports and their own study, Dion et al
(1986) recommended more stringent guidelines for laboratory
containment of MMTV, to prevent zoonotic transmission of the
virus. The question remains how the general population acquires
the MMTV detected in breast cancer specimens.
House mice, of the genus Mus, range naturally across Asia,
Europe and North Africa, but do not inhabit the circumpolar
region above the treeline (Forsyth, 1985). The evolutionary rela-
tionships and biogeography of these mice are now well understood
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Canada K1S 0L6. E-mail: tstewottcan@msn.com(Boursot et al, 1993; Sage et al, 1993). The taxonomy for naming
the evolutionary lineages of mice is contentious, some calling
them three subspecies of M. musculus (Boursot et al, 1993), while
others treat them as three separate species, namely M. domesticus,
M. musculus and M. castaneus (Sage et al, 1993). We use the full-
species taxonomy because it emphasizes the distinctiveness of
these different mice. The native ranges of the three species are
non-overlapping, and where they meet there are comparatively
narrow zones of hybridization (Sage et al, 1993). Broadly
speaking,  M. musculus ranges from central Europe east to China
and Japan, M. castaneus occurs from southern China to central
Iran, and M. domesticus lives from western Iran to western Europe.
M. domesticus mice also expanded their range to North and South
America, Australia, New Zealand and Hawaii via ships sailing
from western European ports. Inbred laboratory mice have mostly
M. domesticus genes (Callahan, 1996), although some inter-
breeding with M. musculus imported from China and Japan has
occurred (Blank et al, 1986).
MMTV has been studied mostly in inbred strains of mice
(Traina-Dorge and Cohen, 1983). What little is known about
MMTV in wild mice suggests that it is common and exists in even
greater diversity than in inbred mice (Callahan et al, 1986). The
virus occurs either as independent exogenous infectious particles
that cause mammary tumours or as a part of the rodent’s germline
genome (endogenous provirus). Exogenous virus was detected in
about 50% of M. domesticus mice from Southern California
(Rongey et al, 1973) and in 43% of M. musculus from Moscow
(Pogossiantz, 1956). Data on the presence of exogenous virus in
M. castaneus mice are lacking.
Mouse species differ in the numbers of endogenous MMTV
proviral loci, with M. musculus and M. castaneus having the
fewest and M. domesticus having the most (P < 0.02, Table 1).
Laboratory colonies of feral mice have been established from
different geographic locations. Descendants of these wild M.
musculus mice collected at six Asian (Callahan et al, 1982; Imai et
al, 1994) and one Czech locality had no (0) complete locus
(Callahan et al, 1982; Jouvin-Marche et al, 1992). At two Asian
localities (Imai et al, 1994) and two Czech localities mice had 1–2
loci, and at one Austrian locality mice had 2 loci (Jouvin-Marche
et al, 1992). M. castaneus mice from three Asian localities had 0
locus (Taiwan), 1–2 loci (Indonesia) and 3 loci (Malaysia) respec-
tively (Imai et al, 1994). Most wild M. domesticus mice assayed
have been from North America, where this species was introduced
from Europe. Colonies were established from feral mice from six
Delaware–Maryland localities (Callahan et al, 1986), four
California localities (Cohen and Varmus, 1979), and two localities
in Morocco (Callahan et al, 1982). One North American and one
Moroccan colony had no complete endogenous locus, 1–2 loci
were found in one Moroccan and three North American colonies,
and seven North American colonies had 3–5 loci. The number of
endogenous loci ranges from 3 to 8 in the classical inbred strains
(Kozak et al, 1987). Wild M. domesticus mice from Europe have
apparently never been genotyped. However, the high numbers of
loci in their North American descendants and in the classical lab
strains suggests that European M. domesticus will also have higher
average numbers of proviral loci than M. musculus mice. Since the
exogenous infectious particles appear to evolve repeatedly from
different endogenous viruses (Doolittle et al, 1989; Brandt-
Carlson et al, 1993), and because exogenous virus can recombine
with endogenous virus to generate a novel variant with broadened
host range (Golovkina et al, 1994), we expect that mouse popula-
tions with more endogenous loci will have more kinds of infec-
tious MMTV.
Since mouse species differ in their numbers of proviral loci and
perhaps in the frequency of exogenous infections, we asked
whether HBC incidence differs in the lands of the three species of
mice.
MATERIALS AND METHODS
The distribution in the number of endogenous MMTV loci in feral
mouse colonies was compared for all known published reports and
ranked in two categories: 0 complete locus and 1–2 loci in one
category, and 3–8 loci in the other. The proportion of observations
in the different categories was compared to the distribution
expected from random occurrence using Fisher’s exact test and
was considered significant at the P < 0.05 level.
HBC incidence per 100 000 (world age-standardized incidence
rate by site), taken from Parkin et al (1997) was compared between
different countries grouped according to the natural range of their
resident species of house mouse (Boursot et al, 1993; Sage et al,
1993). Two geographic regions were considered: western and
eastern Europe, where a clear dichotomy in the native ranges of the
different species of house mice exists, and the rest of the world,
where M. domesticus has been introduced in many countries by
colonization from European sailing ships. Means of HBC inci-
dence were compared by independent samples T test using the
statistical program SPSS and considered significant at the P < 0.05
level.
RESULTS
In Europe there is an abrupt change in the distribution of M.
domesticus and M. musculus, with a well characterized narrow
hybrid zone that runs through central Europe (Sage et al, 1993).
Figure 1A shows the western European distribution of M. domes-
ticus, the eastern European distribution of M. musculus and the
narrow hybrid zone (Sage et al, 1993). Figures 1B and 1C show
the HBC incidence (Parkin et al, 1997) in lands of M. domesticus
and  M. musculus. HBC incidence is 54% higher in western
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Table 1 Number of feral mouse colonies for M. musculus, M. castaneus
and M. domesticus from different localities sorted by number of endogenous
MMTV copies and compared to inbred M. domesticus strains
M. musculus M. castaneus M. domesticus M. domesticus
(inbred)
n 12 3 13 13
MMTV
copy no.
0 71 2 0
1–2 51 4 0
3–8 01 7 1 3
Each feral mouse colony was established from at least one pair of breeding
founders caught at a given locality (Cohen and Varmus, 1979; Callahan et al,
1982, 1986; Jouvin-Marche et al, 1992; Imai et al, 1994). Data for inbred
strains are from Kozak et al (1987). The modal number of endogenous
MMTV loci in feral M. musculus is 0, for M. castaneus is 1–2, and for M.
domesticus is 3–8. Feral M. domesticus mice are significantly more likely to
have 3–8 endogenous loci than the other feral mice (P = 0.011 by Fisher’s
exact test).European lands of M. domesticus than eastern European lands of
M. musculus. This difference is statistically highly significant 
(P < 0.001, see Table 2). HBC incidence data published in 1969
for these same countries (Doll, 1969) show that the same relative
difference has been maintained over 30 years (data not shown).
Cancer incidence in Finland is higher than expected for an M.
musculus land (Table 2). M. musculus mice in Finland were shown
to have nuclear DNA of M. musculus but mitochondrial DNA of
M. domesticus (Prager et al, 1993), suggesting that MMTV of M.
domesticus mice might also be in Finland, explaining the high
incidence in Finland.
In Table 3, HBC incidence (Parkin et al, 1997) in other lands
having M. domesticus is compared to regions where M. domesticus
is not found. Here too the incidence rates stay high (P < 0.001),
even though the environments of these foreign lands vary enor-
mously in temperature, rainfall, and native biota. The potential
oncogenic factor for high HBC incidence common to most of the
world is the presence of M. domesticus and its MMTV. We would
emphasize that these strong correlations do not demonstrate cause,
but demand an explanation.
DISCUSSION
A frequently cited explanation for a high incidence of HBC is
standard of living. However, the relatively high standard of living
in Taiwan, Japan, Hong Kong and Singapore does not equate with
a high incidence of HBC, quite the contrary. The age standardized
rate (ASR) for Taiwan is 17 (Chie et al, 1995), Japan, 26; Hong
Kong, 34; and Singapore, 39 (Parkin et al, 1997). In contrast, we
show that a high incidence of HBC is found in the range of one
mouse species.
Many parallels in mouse and HBC oncogenesis and pathology
exist. First, in the mouse, MMTV itself does not carry a trans-
forming oncogene but acts as an insertional mutagen with several
proviral insertion loci (Nusse, 1991). Wnt1 and Wnt3 are two
genes that cause mammary tumours in mice, when activated by
MMTV. In women, the related genes Wnt2, Wnt4 and Wnt7b are
associated with abnormal proliferation in human breast tissue
(Huguet et al, 1994). The human homologue of mouse Wnt10b,
shown to cooperate with FGF3 in the development of MMTV-
induced mouse mammary carcinomas, is upregulated in human
breast carcinomas (Bui et al, 1997). These observations are
compatible with the effect of an insertional mutagen in women.
Second, breast cancer oncogenesis in the mouse is stimulated by
T-cell immune reaction to the superantigen of MMTV (Wei et al,
1993). A direct effect of MMTV superantigen is a profound and
unambiguous specific T-cell deletion, based predominantly on Vb
expression. Human T-cells also respond to MMTV-encoded super-
antigen with Vb restriction (Labrecque et al, 1993). Third,
immunosuppression decreases the incidence of murine breast
cancers (Stewart and Heppner, 1997). Similarly, fully immuno-
suppressed women (those receiving cyclosporin, azathioprine and
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Figure 1(A) Western European distribution of M. domesticus (heavy
stippling), the eastern European distribution of M. musculus (light stippling)
and the narrow hybrid zone (hatched) where both species are found (Sage 
et al, 1993). The boundary of M. domesticus and M. musculus distribution is
poorly known in central Scandinavia (?). (B, C) HBC incidence per 100 000
annotated for each country. Incidence for N. Ireland, Belgium, Portugal,
Moldova, Romania, Ukraine and Lithuania are from Doll (1969). All other
values are from Parkin et al (1997)steroids) show a 44% reduction in the incidence of breast cancer,
but a significant increase in many other cancers (Stewart et al,
1995), supporting a parallel immune promotion of breast cancer
oncogenesis in humans and mice. These observations support our
hypothesis, given the finding of MMTV DNA in 38–40% of HBC
(Wang et al, 1995).
The possibility of a rodent-borne virus causing this major
human disease and accounting for almost half of its incidence
should not be surprising nor unexpected. Almost 20 years ago,
Day et al (1981) drew this same conclusion from the geographic
variation in immunological responses to antigens of MMTV in the
sera of patients with breast cancer. Precedence for the hypothesis
that retroviruses cause human cancers exists. For example, human
T-cell leukaemia virus (HTLV-1) is associated with adult T-cell
leukaemia (Tajima and Cartier, 1995). There is evidence that
HTLV-1 was acquired by zoonotic infection from rats and mice
(Fukui et al, 1983). M. domesticus has lived with humans, as an
intimate commensal, since the beginnings of agricultural societies
in the Near East (Auffray et al, 1988). The existence of regulatory
food standards allowing up to two pellets of rodent excreta per pint
of wheat (US pt = 551 cm3) confirm the presence of mice in the
modern human food chain (Gecan et al, 1980).
A number of ‘new’ human diseases associated with rodents
have recently been described (Mills and Childs, 1998). Many
major human diseases have shifted to us from our domesticated
animals. Antibodies to intracytoplasmic A-type particles of
MMTV have been found in domesticated mammals (Zotter, 1983),
suggesting cross-species infectivity of MMTV. MMTV has been
shown to replicate in cultured cells of rat, cat, dog, mink and
human breast cancer (Lasfargues et al, 1976a, 1976b, 1979;
Ringold et al, 1977; Howard and Schlom, 1980). Breast-fed
infants of mothers who subsequently develop breast cancer are 
not at higher risk of developing the disease (Titus-Ernstoff et al,
1998), suggesting that an oncogenic human virus is not vertically
MMTV zoonosis and human breast cancer 449
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Table 2 HBC incidence (Parkin et al, 1997) per 100 000 (world age-standardized incidence rate by site)
in western European lands of M. domesticus, lands intersected by the hybrid zone, and eastern
European lands of M. musculus
Lands of M. domesticus Lands of the hybrid zone Lands of M. musculus
Spain (9) 46a Croatia 37 Belarus 30
W. Germany (Saarland) 62 Yugoslavia 43 Latvia 34
Ireland 64 Slovenia 46 Estonia 36
England & Wales 69 E. Germany 48 Slovak Republic 39
Switzerland (8) 69a Norway 54 Poland (3) 40a
Italy 72 Austria (Tyrol) 65 Czech Republic 45
France (8) 75a Sweden 73 Finland 65
Iceland 79 Denmark 73
Netherlands 80
64.5 ± 13.61 53.6 ± 13.52 41.8 ± 10.06
Mean ± s.d.
aValues are weight means of incidence at multiple localities within a given country (number of localities
indicated in parentheses). Difference between breast cancer incidence in lands of M. domesticus and M.
musculus, P < 0.001, by independent-samples t-test.
Table 3 HBC incidence (Parkin et al, 1997) per 100 000 (world age-standardized incidence rate by site) in lands where
M. domesticus is the resident native or introduced species of house mouse compared to lands inhabited by M.
musculus, M. castaneus and other mice
Lands of M. domesticus Lands inhabited by other mice
Algeria 10 South Korea 7
Ecuador 27 Thailand (2) 12a
Costa Rica 29 Taiwan 17b
Peru (2) 31a Vietnam 18
Columbia 39 India (5) 21a
Brazil (3) 44a China (2) 26a
Puerto Rico 46 Japan (6) 26a
Argentina 60 Circumpolar Inuit 34c
Australia 67
Canada 77
New Zealand 77
Israel 77
USA (11) 79a
Uruguay (Montevideo) 93
Hawaii 97
66.0 ± 27.14 21.7 ± 8.12
Mean ± s.d.
aValues are weight means of incidence at multiple localities within a given country (number of localities indicated in
parentheses). Difference between breast cancer incidence in lands of M. domesticus and other mice, P < 0.001, by
independent-samples t-test. bData are from Chie et al (1995). cData are from Miller and Gaudette (1996). There are no
mice of the genus Mus in the circumpolar Inuit environment (Forsyth, 1985).450 THM Stewart et al
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transmitted from mother to infant. However, these results do not
exclude a zoonotic hypothesis of MMTV acquired with every new
generation. Molecular and geographic evidence is becoming an
acceptable alternative to Koch’s postulates for identifying
pathogens of new diseases (Mills and Childs, 1998). The co-occur-
rence of the highest incidence of HBC in the presence of M.
domesticus leads to testable predictions.
Prediction 1
The proportion of tumours testing positive for MMTV DNA
should be lowest in M. musculus and M. castaneus lands. Tentative
support of this prediction already exists: DNA studies of histo-
logical sections (Haga et al, 1994) and immunological studies
(Day et al, 1981) found signs of MMTV in only 5% of patients in
Asian countries. The report (Wang et al, 1995) of 38–40% of
tumours positive for MMTV were from North American patients,
living in the land of M. domesticus. Moreover, the immunosup-
pressed transplant patients showing a 44% reduction in breast
cancer incidence are from western Europe and North America
(Stewart et al, 1995). A similar high incidence of MMTV DNA is
expected in tumours from patients living in western Europe, South
America, Australia, New Zealand and Hawaii.
Prediction 2
People who live and work where M. domesticus is especially
common should have a higher MMTV seroprevalence than those
not so directly exposed to mice. A cross-sectional and longitudinal
sero-epidemiological study of women attending mammography
screening clinics should be conducted. We predict that MMTV
seronegative women will have a lower prevalence and incidence of
HBC compared with MMTV seropositive women.
Prediction 3
Tissues from human tumours testing positive for MMTV should
produce mammary tumours when injected into uninfected mice,
while MMTV-negative human tumours should not. Significantly,
the feasibility of this approach has already been demonstrated by
the experiments of Medvedev in the early 1950s, who was able to
cause uninfected mice to develop mammary tumours when
injected with extracts from human breast tumours, as cited in
(Pogossiantz, 1956).
If the higher incidence of HBC in lands of M. domesticus
reflects oncogenic MMTV zoonosis, then this raises the real possi-
bility of reducing breast cancer incidence by the development of
an MMTV vaccine.
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